MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST EP News Bureau Oct 29, 2024 NPPA has issued an OM directing the concerned manufacturers to reduce the maximum retail price on Trastuzumab, Osimertinib and…
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced… EP News Bureau Nov 22, 2023 Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer… EP News Bureau Jul 17, 2023 Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…
